We are happy to invite you to our satellite session, which will take place during the ESMO GI – 2017 Congress, on Friday 30th June 2017 from 18.00 to 19.00 CET.

The session will be an occasion to discover our association, its objectives, missions, activities and Members. Some of our members will present their national policy activities to gather ideas and inspirations for groups across Europe.

The session will be concluded by an open floor discussion around pancreatic cancer advocacy and awareness efforts. Please note that the access to the sole PCE event will be free for our registered invitees. Access to the whole ESMO GI Congress remains fee-based.

If you wish to participate to the PCE satellite session, please register here. Registrations will close on 23 June 2017. The number of participants is limited.

Did you know that Pancreatic Cancer has the lowest survival rate of all cancers?

Due to severe underdiagnosis, the overall median survival for a person diagnosed with metastatic pancreatic cancer is 4.6 months1.

Pancreatic Cancer Europe and United European Gastroenterology developed in November 2016 an infographic to raise awareness of Pancreatic Cancer. Feel free to download it and spread the word!

 

 

Pancreatic cancer is currently the 4th leading cause of death by cancer in Europe. If no action is taken, it is set to be 2nd by 20202. Help us to reverse the Trend!

Launched in July 2014 a call for action on pancreatic cancer by Members of the European Parliament has been the key driver for the activities of the platform. Since its launch, Pancreatic Cancer Europe has been developping the Pancreatic Cancer Declaration, in order to ensure real change in European policies for pancreatic cancer patients.

European mortality rates of pancreatic cancer
compared with other diseases

Deaths per 100.000 population

Source: Malvezzi M, Bertuccio P, Levi F, La Vecchia C, Negri E, et al. European cancer mortality predictions for the year 2013. Annals of Oncol. 2013; 24:792-800

Patients affected with pancreatic cancer lose 98% of their healthy life expectancy at the point of diagnosis1.

Today, a diagnosis of pancreatic cancer is generally associated with a death sentence and few patients are alive one year after diagnosis, while an earlier diagnosis could help reduce the mortality of the disease. If diagnosed in time, chances of survival increase.

  1. Carrato A, Falcone A, Ducreux, M, Valle, J, Parnaby A, Djazouli K, Alnwick-Allu K, Hutchings A, Palaska C, Parthenaki I. A systematic review of the burden of pancreatic cancer in Europe: Real-world impact on survival, quality-of-life, and costs. J Gastrointest Cancer 2015 Sep;46(3):201-11
  2. Pancreatic Cancer Action Network. The alarming rise of pancreatic cancer deaths in The United States: Why we need to stem the tide today, 2012. www.pancan.org/wp-content/uploads/2013/01/incidence_report_2012_executive_summary.pdf [Last accessed April 2014]
  3. Ipsos. 2014. Global Omnibus Research: Pancreatic Cancer Awareness Survey.
  4. Malvezzi M, Bertuccio P, Levi F, La Vecchia C, Negri E, et al. European cancer mortality predictions for the year 2013. Annals of Oncol. 2013; 24:792-800
  5. Jpn. J. Clin. Oncol. (2004) 34 (5):238-244.
  6. Carrato et al, 2015. “A Systematic Review of the Burden of Pancreatic Cancer in Europe: Real-World Impact on Survival, Quality of Life and Costs.” DOI 10.1007/s12029-015-9724-1
  7. Farthing, M, Roberts, S, Samuel D, Williams D, et al. Survey of digestive health across Europe: Final report. Part 1: The burden of gastrointestinal diseases and the organisation and delivery of gastroenterology services across Europe, United European Gastroenterology Journal, December 2014 vol. 2 no. 6 539-543
  8. Malvezzi 2014. Annals of Oncology. European cancer mortality predictions for the year 2014
  9. Carrato et al, 2015. “A Systematic Review of the Burden of Pancreatic Cancer in Europe: Real-World Impact on Survival, Quality of Life and Costs.” DOI 10.1007/s12029-015-9724-1
  10. “15 facts on Pancreatic Cancer”, European Cancer Patient Coalition (ECPC) www.ecpc.org/edu/ pancreas/249-15-key-facts-on-pancreatic-cancer
  11. Malvezzi M, Bertuccio P, Levi F, La Vecchia C, Negri E, et al. European cancer mortality predictions for the year 2013. Annals of Oncol. 2013; 24:792-800
  12. Carrato et al, 2015. “A Systematic Review of the Burden of Pancreatic Cancer in Europe: Real-World Impact on Survival, Quality of Life and Costs.” DOI 10.1007/s12029-015-9724-1
  13. Farthing, M, Roberts, S, Samuel D, Williams D, et al. Survey of digestive health across Europe: Final report. Part 1: The burden of gastrointestinal diseases and the organisation and delivery of gastroenterology services across Europe, United European Gastroenterology Journal, December 2014 vol. 2 no. 6 539-543